| Mark E Ritter, MD | |
|
2022 Kelle Dr, Chesterton, IN 46304-8708 | |
| (219) 395-2200 | |
| (219) 983-1837 |
| Full Name | Mark E Ritter |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 38 Years |
| Location | 2022 Kelle Dr, Chesterton, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609939511 | NPI | - | NPPES |
| 110219045 | Other | IN | RAILROAD PROVIDER NUMBER |
| 000000203749 | Other | IN | PROVIDER BCBS NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 01037402A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Porter Home Health | Valparaiso, IN | Home health agency |
| Northwest Health - Porter | Valparaiso, IN | Hospital |
| St Mary Medical Center Inc | Hobart, IN | Hospital |
| Franciscan St Anthony Health - Michigan City | Michigan city, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Porter Physician Services Llc | 1850482407 | 91 |
News Archive
In a breach of patient trust, a British hospital shared the personal information of around 1.6 million patients with Google's DeepMind. This was reported by a British data protection watchdog - Information Commissioner's Office (ICO) yesterday, creating a stir. The deal between the Royal Free NHS Trust and Google's DeepMind first became known to the public in February 2016.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Suffering from injuries to his brain, nerves, and tendons for over four years, 45-year-old John Fratti of Hummelstown, PA, has taken on the Food and Drug Administration with good results. Since taking Johnson & Johnson's antibiotic Levaquin for an infection he has had many diagnostic studies on his brain and body that show considerable damage. Healthy and athletic at 41 years of age, he now takes multiple prescription pain medications for his injuries.
Cancer is usually attributed to faulty genes, but growing evidence from the field of cancer epigenetics indicates a key role for the gene "silencing" proteins that stably turn genes off inside the cell nucleus. A new study from Rice University and Baylor College of Medicine promises to speed research in the field by rapidly identifying the genes that epigenetic proteins can target for silencing.
› Verified 1 days ago
| Entity Name | Porter Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508075680 PECOS PAC ID: 1850482407 Enrollment ID: O20070810000409 |
News Archive
In a breach of patient trust, a British hospital shared the personal information of around 1.6 million patients with Google's DeepMind. This was reported by a British data protection watchdog - Information Commissioner's Office (ICO) yesterday, creating a stir. The deal between the Royal Free NHS Trust and Google's DeepMind first became known to the public in February 2016.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Suffering from injuries to his brain, nerves, and tendons for over four years, 45-year-old John Fratti of Hummelstown, PA, has taken on the Food and Drug Administration with good results. Since taking Johnson & Johnson's antibiotic Levaquin for an infection he has had many diagnostic studies on his brain and body that show considerable damage. Healthy and athletic at 41 years of age, he now takes multiple prescription pain medications for his injuries.
Cancer is usually attributed to faulty genes, but growing evidence from the field of cancer epigenetics indicates a key role for the gene "silencing" proteins that stably turn genes off inside the cell nucleus. A new study from Rice University and Baylor College of Medicine promises to speed research in the field by rapidly identifying the genes that epigenetic proteins can target for silencing.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark E Ritter, MD 2022 Kelle Dr, Chesterton, IN 46304-8708 Ph: (219) 364-3616 | Mark E Ritter, MD 2022 Kelle Dr, Chesterton, IN 46304-8708 Ph: (219) 395-2200 |
News Archive
In a breach of patient trust, a British hospital shared the personal information of around 1.6 million patients with Google's DeepMind. This was reported by a British data protection watchdog - Information Commissioner's Office (ICO) yesterday, creating a stir. The deal between the Royal Free NHS Trust and Google's DeepMind first became known to the public in February 2016.
GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.
Suffering from injuries to his brain, nerves, and tendons for over four years, 45-year-old John Fratti of Hummelstown, PA, has taken on the Food and Drug Administration with good results. Since taking Johnson & Johnson's antibiotic Levaquin for an infection he has had many diagnostic studies on his brain and body that show considerable damage. Healthy and athletic at 41 years of age, he now takes multiple prescription pain medications for his injuries.
Cancer is usually attributed to faulty genes, but growing evidence from the field of cancer epigenetics indicates a key role for the gene "silencing" proteins that stably turn genes off inside the cell nucleus. A new study from Rice University and Baylor College of Medicine promises to speed research in the field by rapidly identifying the genes that epigenetic proteins can target for silencing.
› Verified 1 days ago
Dr. Amarnath Badriprasad Agrawal, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1882 Catkin Cir, Chesterton, IN 46304 Phone: 219-395-8609 Fax: 219-395-8609 | |
Jamie Chin-theodorou, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 Village Pt Ste 102, Chesterton, IN 46304 Phone: 219-395-1046 Fax: 219-395-1570 | |
John Patrick Brady, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 Village Point, Suite 102, Chesterton, IN 46304 Phone: 219-395-1046 Fax: 219-395-1570 | |
Prasanthi Tummuru, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1140 S Calumet Rd, Chesterton, IN 46304 Phone: 219-926-6717 | |
Aleksander Skarzynski, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Summitt Dr, Chesterton, IN 46304 Phone: 219-787-8525 | |
Dr. James Arthur Hasbargen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 Village Point, Suite 102, Chesterton, IN 46304 Phone: 219-395-1046 Fax: 219-395-1570 |